Literature DB >> 7592914

Identification and characterization of a kappa B/Rel binding site in the regulatory region of the amyloid precursor protein gene.

M Grilli1, M Ribola, A Alberici, A Valerio, M Memo, P Spano.   

Abstract

Several observations support the hypothesis that pathogenetic mechanisms of beta amyloid formation in Alzheimer's disease may involve alterations in amyloid precursor protein (APP) gene expression. In this regard, molecular dissection of the APP gene transcriptional regulation is of primary importance. We report evidence that members of the family of transcription factors NF kappa B/Rel can specifically recognize two identical sequences located in the 5'-regulatory region of APP. These sequences, which we refer to as APP kappa B sites, interact preferentially with p50-containing members of the family. In particular, p50 homodimers and p50/p65 and p50/c-Rel heterodimers act as transcriptional activators at the APP kappa B site. Finally, the nuclear complex specifically binding to the APP kappa B sites proves to be an integral part of neurons and lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7592914     DOI: 10.1074/jbc.270.45.26774

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Comparative analysis of Alu insertion sequences in the APP 5' flanking region in humans and other primates.

Authors:  Jordi Clarimón; Aida M Andrés; Jaume Bertranpetit; David Comas
Journal:  J Mol Evol       Date:  2004-06       Impact factor: 2.395

2.  Neuroinflammatory and Amyloidogenic Activities of IL-32β in Alzheimer's Disease.

Authors:  Hyung-Mun Yun; Jin A Kim; Chul Ju Hwang; Peng Jin; Myung Ki Baek; Jin Moo Lee; Ji Eun Hong; Sang Min Lee; Sang Bae Han; Ki Wan Oh; Dong Young Choi; Do Young Yoon; Jin Tae Hong
Journal:  Mol Neurobiol       Date:  2014-08-27       Impact factor: 5.590

Review 3.  Roles for NF-κB and gene targets of NF-κB in synaptic plasticity, memory, and navigation.

Authors:  Wanda M Snow; Brenda M Stoesz; Debbie M Kelly; Benedict C Albensi
Journal:  Mol Neurobiol       Date:  2013-10-13       Impact factor: 5.590

4.  Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease.

Authors:  Jessie Theuns; Nathalie Brouwers; Sebastiaan Engelborghs; Kristel Sleegers; Veerle Bogaerts; Ellen Corsmit; Tim De Pooter; Cornelia M van Duijn; Peter P De Deyn; Christine Van Broeckhoven
Journal:  Am J Hum Genet       Date:  2006-04-10       Impact factor: 11.025

5.  Microsatellite instability in Arabidopsis increases with plant development.

Authors:  Andrey Golubov; Youli Yao; Priti Maheshwari; Andriy Bilichak; Alex Boyko; François Belzile; Igor Kovalchuk
Journal:  Plant Physiol       Date:  2010-09-03       Impact factor: 8.340

Review 6.  Molecular basis of etiological implications in Alzheimer's disease: focus on neuroinflammation.

Authors:  Rituraj Niranjan
Journal:  Mol Neurobiol       Date:  2013-02-19       Impact factor: 5.590

7.  Extracellular Mitochondria and Mitochondrial Components Act as Damage-Associated Molecular Pattern Molecules in the Mouse Brain.

Authors:  Heather M Wilkins; Scott J Koppel; Ian W Weidling; Nairita Roy; Lauren N Ryan; John A Stanford; Russell H Swerdlow
Journal:  J Neuroimmune Pharmacol       Date:  2016-08-25       Impact factor: 4.147

8.  Effects of immunomodulatory substances on phagocytosis of abeta(1-42) by human microglia.

Authors:  Erik Hjorth; Dan Frenkel; Howard Weiner; Marianne Schultzberg
Journal:  Int J Alzheimers Dis       Date:  2010-05-20

9.  Phagocytosis and LPS alter the maturation state of β-amyloid precursor protein and induce different Aβ peptide release signatures in human mononuclear phagocytes.

Authors:  Philipp Spitzer; Martin Herrmann; Hans-Wolfgang Klafki; Alexander Smirnov; Piotr Lewczuk; Johannes Kornhuber; Jens Wiltfang; Juan Manuel Maler
Journal:  J Neuroinflammation       Date:  2010-10-07       Impact factor: 8.322

Review 10.  The role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in Alzheimer's disease: therapeutic implications.

Authors:  Qingguang Jiang; Michael Heneka; Gary E Landreth
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.